BioSpace News Archive

The rising incidence of injuries and bone dislodgement has driven demand within the global femoral prostheses market.

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced top-line results from its 755-102-HV Phase 1 clinical trial (“Study 102").

In order to up their sales and revenues, savvy companies in the global guidewires market are expending time and money on research and development of better products having sophisticated features to cater to various medical procedures.

Transparency Market Research in a new market study reports that the global vitreous tamponades market is highly fragmented with the presence of small and medium sized players.

Accuray Incorporated will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market close on Wednesday January 27, 2021.

AiCuris Anti-infective Cures GmbH, a leading company in the discovery and development of drugs against infectious diseases, today announced that Dr. Holger Zimmermann, CEO of AiCuris, will present at the 39th Annual J.P. Morgan Healthcare Conference (11-14 Jan., 2021) on Thursday, January 14, 2021 at 08:05 am to 08:30 am Eastern Time (02:05 pm to 02:30 pm Central European Time).

Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020. • Consolidated gross sales across all locations during November 2020 totaled $3.4 million, representing a 6.3% year-over-year growth when compared with November 2019. • Prescriptions filled during November came in at appr

OTTAWA, ON , Jan. 8, 2021 /CNW/ - Note: All times local Ottawa, Ontario Private meetings. 11 :30 a.m. The Prime Minister will address Canadians on the COVID-19 situation. A media availability will follow. Rideau Cottage 1 Sussex Drive Notes for media:

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Michelon will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnologies initiatives, today announced that it has increased its product liability insurance “Aggregate” coverage to $10,000